Clinical trial rules should protect patients and results, not operational details

(European Society of Cardiology) Rules governing the conduct of clinical trials are failing to produce the intended benefits for patients and should be rewritten through a transparent process that involves academic clinical trialists and patient advocates as well as regulators and industry representatives, according to recommendations published today in European Heart Journal.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2n5Zxxa